Impact Factor
3.96
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.75
5,005 total citations
h5-index
78
h5 depth signal
Cited share
61.2%
846 of 1,383
Total citations
5,005
Citation footprint
Metric signal
3.68
External metric anchor
Self-citation
10.6%
532 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
3,026
United Kingdom
671
Canada
526
Australia
457
France
389
Citing Fields of Research
Allergies
4,466
Immunology
541
Hematology
301
Auto-Inflammatory Disorders
298
Dermatology
183
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
7,487
Articles tracked across the journal lifetime
Indexed publication set
1,383
846 cited publications
Last 12 months
581
48.4 publications/month
Open access share
21.0%
122 OA publications in the last year
Leading citing country
United States
3,026 citing publications
Leading citing field
Allergies
4,466 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan. 2013-
v1n1, Jan. 2013-
Research Focus & Classification
Indexed Subjects
Allergies
Issuing & Sponsoring Bodies
issuing body
American Academy of Allergy, Asthma, and Immunology
Broad Categories
Allergy and Immunology
Allergies
MeSH Descriptors
Hypersensitivity
Immune System Phenomena
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.jaip.2026.10.003
Open DOI
Alcohol-Induced Hypersensitivity: A Clinical and Mechanistic Overview
02
DOI 10.1016/j.jaip.2026.10.006
Open DOI
Second-line dupilumab after anti-IL5/Rα failure: remission rates and clinical outcomes in severe asthma
03
DOI 10.1016/j.jaip.2026.10.007
Open DOI
Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease: Diagnosis and Treatment
04
DOI 10.1016/j.jaip.2026.09.029
Open DOI
Inhaled, nasal and topical corticosteroid burden and association with corticosteroid-associated adverse events
05
DOI 10.1016/j.jaip.2026.09.034
Open DOI
Benefits and Harms of Dose Escalation of Inhaled Corticosteroids in Uncontrolled Asthma
06
DOI 10.1016/j.jaip.2026.09.030
Open DOI
Pharmacokinetics, pharmacodynamics, and safety of AQST-109 epinephrine 12mg sublingual film: A Phase I pediatric study
07
DOI 10.1016/j.jaip.2026.09.028
Open DOI
Epinephrine-treated reactions and their severity in preschool children during oral immunotherapy
08
DOI 10.1016/j.jaip.2026.10.004
Open DOI
“Bridging the Gap: Increasing Participation of Underrepresented Populations in Allergy and Immunology Research”
09
DOI 10.1016/j.jaip.2026.09.027
Open DOI
The FAA’s Proposed “Performance-Based” Approach to In-Flight Anaphylaxis Management
10
DOI 10.1016/s2213-2198(26)00737-3
Open DOI
Continuing Medical Education Calendar
Bibliographical & Catalog Notes
Also issued online.
Companion journal to: Journal of allergy and clinical immunology.